Introduction

Discovery of Cdc20
The cell-division cycle consists of a series of complex, interdependent processes that are coordinated by core cell cycle regulatory proteins. The molecular understanding of the cell cycle began when Lee Hartwell and coworkers isolated Cell Division Cycle (CDC) mutants of S. cerevisiae that, despite continued cell growth, failed to execute or complete key cell-cycle events, such as DNA replication or mitosis (Hartwell et al., 1970) . Among the original Hartwell mutant collection were the cdc20 mutants that arrest cell division in mitosis and fail to initiate anaphase and chromosome segregation (Hartwell et al., 1973) . Molecular cloning of the CDC20 gene revealed that it encodes a protein related to the b subunit of trimeric G proteins. Both Cdc20 and Gb contain seven WD40 repeats that form a seven-bladed b propeller structure ideally suited for mediating protein-protein interactions (Figure 1 ). Orthologs of Cdc20 were then discovered in various organisms, including mammals and the fruit fly (Weinstein et al., 1994; Dawson et al., 1995) . In Drosophila, the Cdc20 ortholog, Fizzy, was shown to be required for the degradation of mitotic cyclins A and B (Dawson et al., 1995) . However, the biochemical functions of Cdc20 remained obscure until the discovery of the anaphase-promoting complex/cyclosome (APC/C) (King et al., 1995; Sudakin et al., 1995) . Discovery of APC/C Progression through the cell cycle relies on the periodic fluctuations of the activities of cyclin-dependent kinases (CDKs). Activation of Cdk1 is required for the execution of many if not all events during mitosis whereas inactivation of Cdk1 is a prerequisite for the exit from mitosis. An important mechanism for the inactivation of Cdk1 is the degradation of its positive regulatory subunits, mitotic cyclins A and B, through the ubiquitin-proteasome pathway (Glotzer et al., 1991) . In addition, the same ubiquitin-dependent degradation machinery that degrades mitotic cyclins is also responsible for the degradation of an anaphase inhibitor that blocks the onset of sister-chromatid separation (Holloway et al., 1993) . The convergence of genetic and biochemical studies in yeast and clam and frog egg extracts then identified APC/C as the ubiquitin ligase in this mitotic degradation system (King et al., 1995; Sudakin et al., 1995) . APC/C is a multisubunit enzyme conserved from yeast to man and contains at least 12 core subunits (reviewed in Peters [2006] and ). APC/C becomes active during mitosis and remains active through much of G1. During mitosis, APC/C mediates the ubiquitination of the anaphase inhibitor securin (known as Cut2 in fission yeast and Pds1 in budding yeast) that is an inhibitory chaperone of separase (reviewed in Nasmyth [2002] ). Degradation of securin activates separase, which cleaves the cohesin complex and allows sister-chromatid separation. APC/C also mediates the degradation of mitotic cyclins, resulting in the activation of Cdk1 and mitotic exit. APC/Cdependent degradation of mitotic cyclins and other mitotic regulators persists in G1, preventing their premature accumulation during the cell cycle. Discovery of Cdc20 as an Activator of APC/C The S. cerevisiae cdc20 mutants fail to initiate anaphase, suggesting that Cdc20 might be required for the activation of APC/C at the metaphase-anaphase transition.
Furthermore, Cdc20 and Cdc20 homolog 1 (Cdh1; also known as Hct1 for homolog of Cdc twenty) apparently mediate degradation of distinct subsets of APC/C substrates in budding yeast (Schwab et al., 1997; Visintin et al., 1997) . This finding suggests that the Cdc20/Cdh1 family of proteins serve as substrate-specific activators of APC/C. In Drosophila, fizzy is required for the degradation of mitotic cyclins and for anaphase onset whereas the fizzy-related (the ortholog of Cdh1) gene is responsible for the continued degradation of these cyclins in G1 (Sigrist and Lehner, 1997) . This suggests that Cdc20 and Cdh1 regulate APC/C during different phases of the cell cycle. It was later shown that Cdc20 and Cdh1 directly bind to APC/C and activate its ubiquitin ligase activity toward cyclin B in vitro (Fang et al., 1998b) . Binding of Cdc20 to APC/C requires phosphorylation of core APC/C subunits by Cdk1 and other mitotic kinases (Fang et al., 1998b; Kraft et al., 2003) . In contrast, CDK-dependent phosphorylation of Cdh1 prevents its binding to APC/C (Zachariae et al., 1998a) . Thus, Cdc20 activates APC/C predominantly in mitosis when CDK activities are high whereas Cdh1 mainly interacts with APC/C in telophase/G1 when CDK activities are low. Finally, ubiquitination in vitro by APC/C Cdc20 and APC/C Cdh1 requires different sequence motifs within the APC/C substrates (Fang et al., 1998b; Pfleger and Kirschner, 2000) . Collectively, these findings demonstrate that Cdc20 and Cdh1 are activators of APC/C that function during different phases of the cell cycle and contribute to the substrate specificity of APC/ C. This topic has been covered by several excellent recent reviews (Peters, 2006; . In this article, I focus on the recent progress on the functions, mechanism, and regulation of Cdc20, highlighting results that have altered or refined our views in these areas.
Functions of Cdc20
A typical cell-division cycle of a human cell lasts about 24 hr. Though mitosis only occupies about 2 hr of this 24 hr cycle, a series of complicated interdependent cellular events are accomplished during this relatively short period of time, including nuclear envelope breakdown, fragmentation of cellular organelles such as the endoplasmic reticulum (ER) and the Golgi apparatus, chromosome condensation, formation of the mitotic spindle, chromosome congression and segregation, and finally cytokinesis. Many of these events involve global changes in the cytoskeleton and membranes of the cell, and yet they are completed on the time scale of minutes. Due to its relatively fast kinetics and its irreversibility, ubiquitindependent proteolysis is ideally suited for the regulation of the rapid and orderly progression through mitosis. The best-characterized biochemical activity of Cdc20 is to activate APC/C during mitosis. Therefore, the major function of Cdc20 is to coordinate mitotic progression by facilitating the orderly degradation of mitotic APC/C substrates. Essential Functions of APC/C Cdc20 CDC20 and most genes that encode core APC/C subunits are essential for viability in yeast (Zachariae et al., 1998b) . Their corresponding orthologs in mammals are also essential for the completion of the cell-division cycle (Wirth et al., 2004) . In contrast, CDH1 is not essential for viability in yeast (Schwab et al., 1997; Visintin et al., 1997) . Depletion of Cdh1 by RNA interference (RNAi) from human cells does not significantly perturb the cell cycle (Qi and Yu, 2007) . Therefore, APC/C Cdc20 is capable of mediating the degradation of critical mitotic APC/C substrates. Thornton and Toczyski reasoned that if the only essential functions of APC/C were to mediate the degradation of mitotic regulators, genetic ablation of such regulators would then rescue the lethality of APC/C mutants (Thornton and Toczyski, 2003) . Indeed, deletion of the CLB5 (a mitotic cyclin) and PDS1 (yeast securin) genes and integration of about ten copies of the SIC1 gene (a mitotic CDK inhibitor) renders the essential APC/ C subunits dispensable for the viability of budding yeast cells (Thornton and Toczyski, 2003) . This result suggests that securin and mitotic cyclins are the only essential substrates of APC/C in budding yeast. In mammalian cells, expression of nondegradable securin causes incomplete sister-chromatid separation (Zur and Brandeis, 2001 ). Elevated levels of cyclin A delay the metaphaseanaphase transition (Geley et al., 2001) . Depending on the levels of expression, nondegradable cyclin B arrests cells at metaphase or in anaphase (Wolf et al., 2006) . Thus, degradation of securin and mitotic cyclins appears to be the essential task of APC/C Cdc20 in organisms from yeast to man. APC/C Cdc20 and Mitotic Progression APC/C Cdc20 degrades various mitotic regulators with the correct temporal order to trigger the successive execution of mitotic events. The current available evidence is consistent with the following framework that explains the functions of APC/C Cdc20 and APC/C Cdh1 during mitosis and G1 (Figure 2 ). During early mitosis, the core APC/C subunits become phosphorylated by Cdk1 and other mitotic kinases, enabling efficient binding of Cdc20 to APC/C (Kraft et al., 2003) . Phosphorylation of Cdh1 by CDKs (Zachariae et al., 1998a ) and binding of nucleoporins to Cdh1 (Jeganathan et al., 2005) prevent the activation of APC/C Cdh1 , which ensures that APC/C Cdc20 is the major form of active APC/C in mitosis. The activity of APC/C Cdc20 is further restricted by Emi1 and the spindle checkpoint in early mitosis (see below). APC/C Cdc20 mediates degradation of cyclin A and Nek2A prior to the metaphase-anaphase transition (Geley et al., 2001; Hames et al., 2001) . At the metaphase-anaphase transition, APC/C Cdc20 then degrades securin to relieve one layer of inhibition of separase. APC/C Cdc20 also initiates the degradation of cyclin B at this juncture, lowering the activity of Cdk1 and thus relieving the phosphorylationmediated inhibition of separase (Stemmann et al., 2001) . Active separase then cleaves the Scc1 subunit of the cohesin complex and triggers sister-chromatid separation. Separase that is free of securin is also capable of binding directly to cyclin B and inhibits the activity of Cdk1 (Gorr et al., 2005) . In late anaphase, APC/C Cdc20 -mediated degradation of mitotic cyclins and the direct inhibition of Cdk1 by separase reduce the activities of CDKs to a level that is insufficient to prevent Cdh1 from binding to APC/C, resulting in the activation of APC/ C Cdh1 . APC/C Cdh1 then mediates the degradation of a wider range of APC/C substrates, including Cdc20 (Fang et al., 1998b; Prinz et al., 1998) , as cells undergo exit from mitosis. In G1, APC/C Cdc20 is rendered inactive by the dephosphorylation of APC/C core subunits and At the G1-S transition, E2F activates the transcription of Emi1. The Emi1 protein is stabilized by Evi5. Accumulation of Emi1 inhibits APC/C Cdh1 and stabilizes cyclin A, which activates Cdk2 and promotes entry into S phase. Cdk2 also phosphorylates Cdh1 and further inhibits APC/C Cdh1 . In early mitosis, Cdk1 and other mitotic kinases phosphorylate the APC/C core, promoting its binding to Cdc20. Emi1 inhibits APC/C Cdc20 and prevents the premature destruction of cyclin B. APC/C Cdc20 is also blocked by the spindle checkpoint in response to misaligned chromatids. Plk1-mediated degradation of Emi1 and inactivation of the spindle checkpoint allow activation of APC/C Cdc20 , which promotes the degradation of securin and cyclin B. This in turn leads to the activation of separase, cleavage of cohesin, and anaphase onset. APC/C Cdc20 -dependent degradation of cyclin B and separase binding to cyclin B reduce the Cdk1 activity, resulting in the dephosphorylation of Cdh1 and activation of APC/C Cdh1 in late anaphase. APC/C Cdh1 then orchestrates the degradation of a wide spectrum of substrates, facilitating mitotic exit and cytokinesis.
by APC/C Cdh1 -mediated degradation of Cdc20. In contrast, APC/C Cdh1 remains active in G1 and prevents the premature accumulation of mitotic regulators. APC/ C Cdh1 is also active in certain terminally differentiated cells and has substrates that are not core cell-cycle regulators (reviewed in Peters [2006] ). APC/C-Independent Functions of Cdc20 Several studies in the budding yeast suggest that Cdc20 might have APC/C-independent functions. For example, Cdc20 promotes spindle elongation and premature chromosome segregation in mec1 or rad53 mutants that are defective for the DNA damage checkpoint and are under replication stress (Clarke et al., 2003) . This function of Cdc20 appears to be independent of APC/C, as forced accumulation of Cdc20 induces chromosome segregation even in strains harboring mutations in APC/C subunits. A subsequent study confirmed that the spindle elongation and abnormal chromosome segregation seen in mec1 or rad53 mutants are independent of APC/C and identified two microtubule-associated proteins, Cin8 and Stu2, as additional targets of Mec1 and Rad53 in the S phase checkpoint (Krishnan et al., 2004) . The detailed molecular mechanisms for APC/C-independent functions of Cdc20 have not been established. It is also unclear whether these non-APC/C functions of Cdc20 are conserved in other organisms.
Mechanisms by which Cdc20 Activates APC/C Mechanism of APC/C-Catalyzed Ubiquitination On the basis of their catalytic mechanisms, ubiquitin ligases can be divided into two major classes: the homology to E6AP C terminus (HECT) domain-containing proteins and the RING-finger-containing proteins or protein complexes (reviewed in Pickart [2001] ). The HECT ligases catalyze ubiquitination reactions by transiently accepting ubiquitin as a thioester through their active-site cysteines and then transferring the ubiquitin to substrates. In contrast, the RING-containing ligases do not form ubiquitin-thioester intermediates. Instead, they are capable of binding to ubiquitin-conjugating enzymes (UBCs) and substrates simultaneously, and thus act as scaffolds to bridge the interactions between UBCs and substrates. Binding of RING to UBCs also stimulates the release of ubiquitin from the UBC-ubiquitin thioesters. Therefore, in the presence of RING ligases, the combined proximity effect and the allosteric activation of UBCs allow more efficient ubiquitin transfer from UBCs to substrates.
Among the RING ligases, the so-called Skp1-cullin-F box (SCF) complexes have been characterized extensively (Petroski and Deshaies, 2005) . The SCF ligases contain a cullin-RING module that binds to and activates UBCs and an F box-containing adaptor that recruits substrates for ubiquitination. Many F box-containing adaptors contain WD40 repeats that, in the cases of bTrCP and Cdc4, contact substrates through the top face of their b propeller structures (Orlicky et al., 2003; Wu et al., 2003) . Because the APC2 and APC11 subunits of APC/C contain a cullin homology domain and a RING-finger domain, respectively, it has been anticipated that APC/C catalyzes the ubiquitination of its substrates using a mechanism similar to the SCF type of ubiquitin ligases ( Figure 3A ). Indeed, a binary complex containing only APC2 and APC11 is capable of binding to and activating UbcH10 (the APC/C-specific UBC) in vitro (Tang et al., 2001b) , indicating that APC/C contains a functional cullin-RING module for binding to UBCs, similar to SCF ligases. Like bTrCP and Cdc4, the two APC/C activators Cdc20 and Cdh1 contain WD40 repeats, hinting at a role for Cdc20 and Cdh1 in substrate binding ( Figure 3A ). Though there is little doubt that Cdc20 and Cdh1 facilitate APC/C-mediated ubiquitination through contributing to substrate binding, recent studies paint a complicated picture of how Cdc20 and Cdh1 facilitate the recruitment of substrates to APC/C.
Role of Cdc20 in Substrate Binding
In addition to securin and mitotic cyclins, APC/C mediates the degradation of a multitude of other substrates (Peters, 2006) . Most APC/C substrates contain either or both of two cis elements, called destruction box (D box) (Glotzer et al., 1991) or KEN box (Pfleger and Kirschner, 2000) , which are required for their efficient ubiquitination by APC/C. Fusion of short protein fragments containing these APC/C degrons is often sufficient to target otherwise stable, heterologous proteins for APC/C-dependent ubiquitination and degradation (Glotzer et al., 1991) . Thus, these cis elements are necessary and sufficient for the ubiquitination of substrates by APC/C. Extensive studies have rightly been devoted to the identification of the receptors of these APC/C degrons that hold the key for understanding the substrate specificity and mechanism of APC/C.
Yeast and vertebrate Cdc20 and Cdh1 bind directly to numerous APC/C substrates in vitro (reviewed in Vodermaier [2001] ). In several but not all cases, the interactions between Cdc20/Cdh1 and substrates are dependent on the D or KEN boxes of the substrates, suggesting that Cdc20 and Cdh1 are possible receptors for these APC/ C degrons. Consistently, a D box-containing peptide can be chemically crosslinked to Cdc20 or Cdh1 (Kraft et al., 2005) . This crosslinking requires conserved residues that are predicted to cluster on the top face of the WD40 domain of Cdh1 (Kraft et al., 2005) (Figure 1B ). These findings suggest that the D box directly contacts the WD40 domain of Cdh1 and possibly that of Cdc20. Therefore, Cdc20 and Cdh1 can serve as D box receptors. The difficulty of detecting stable, D box-dependent interactions between free Cdc20 and APC/C substrates may be due to the weak and transient nature of these binding events.
On the other hand, several findings suggest that, in addition to Cdc20 and Cdh1, the APC/C core also contributes to D box binding. First, a peptide containing tandem copies of the D box is able to pull down the APC/C core particle that is largely free of Cdc20 or Cdh1 from Xenopus egg extracts (Yamano et al., 2004) . Second, yeast Doc1 (APC10) is required for D box-dependent substrate processivity of APC/C in an in vitro ubiquitination assay, suggesting that Doc1 plays a rather direct role in the recognition of the D box (Carroll et al., 2005) . Finally, native-gel-based binding assays and ''isotope trapping'' methods have demonstrated that the complex between APC/C and Cdc20 binds to substrates with higher affinity than does either entity alone Eytan et al., 2006) .
Models for Substrate Recognition by APC/C Cdc20
In light of these findings, four models have been proposed to explain Cdc20-dependent substrate recognition by APC/C: (1) sequential transfer, (2) composite binding site, (3) allostery, and (4) multivalency (Yamano et al., 2004; Eytan et al., 2006) ( Figure 3B ). In the sequential transfer model, Cdc20 binds to substrate first through their D or KEN boxes. Upon docking on the APC/C core, it then transfers the substrate to Doc1 or other APC/C subunits. The composite binding site model proposes that the APC/C degrons bind at the interface between APC/C and Cdc20. In the allostery model, binding of Cdc20 to APC/C causes a structural rearrangement of APC/C and/or a conformational change of Cdc20, which reveals a previously blocked D box-binding site. In the multivalency model, APC/C and Cdc20 each contain weak binding sites for D or KEN boxes. Because a given APC/C substrate often contains multiple D or KEN boxes, the APC/C Cdc20 complex can engage the substrate through multivalent weak interactions that synergize to produce high-affinity binding between the two.
A similar set of models can be envisioned for Cdh1-dependent substrate binding by APC/C. These models are not necessarily mutually exclusive. There is supporting evidence for each of the four models. However, the sequential transfer model is inconsistent with the fact that the APC/C Cdc20 complex binds to substrate with higher affinity than either APC/C or Cdc20 alone Eytan et al., 2006) . Likewise, it is difficult for the composite binding site model to explain why tandem copies of D box can interact with APC/C with high affinity in the absence of Cdc20 (Yamano et al., 2004) . On the other hand, the combination of the allostery and multivalency models is consistent with all available data. In support of the allostery model, electron microscopy (EM) studies reveal that human APC/C indeed undergoes a large-scale conformational change upon binding to Cdh1 (Dube et al., 2005) , although it remains to be determined whether this Cdh1-induced conformational change is required for catalysis or substrate binding. In addition, Cdc20 and Cdh1 contain two short motifs called the C box and the IR box that are required for binding to APC/C (Schwab et al., 2001; Vodermaier et al., 2003) ( Figure 1A ). The IR box of Cdh1 has been shown to bind directly to Cdc27 (Vodermaier et al., 2003) . Recent evidence suggests that the C box of Cdh1 binds to an APC2-containing subcomplex that lacks Cdc27 . Based on the tentative architectural map of the yeast APC/C, Cdc27 and APC2 are located in separate (A) Mechanisms of ubiquitination reactions catalyzed by SCF and APC/C. APC/C and the SCF type of ubiquitin ligases are thought to facilitate the transfer of ubiquitin to substrates by primarily acting as scaffolds that bring together ubiquitin-charged UBCs through their RING-finger subunits and substrates through adaptors (Cdc20 and Cdh1 in the case of APC/C and F box proteins in the case of SCF complexes, such as Cdc4 and bTrCP). The ubiquitination reactions are processive, leading to the formation of ubiquitin chains that target the substrates to the proteasome for degradation. To achieve processivity, APC/C and SCF need to support ubiquitin transfer from the UBCs to continuously elongating ubiquitin chains, which requires conformational flexibility of the substrates and/or the ligases in these systems. Along this vein, the degrons of several APC/C substrates are located in regions that adopt flexible conformations (unpublished data). The architecture of cullins and possibly APC2 resembles that of karyopherins and the scaffolding subunit of protein phosphatase 2A, both of which are capable of undergoing large-scale conformational changes.
(B) Four different models that explain the contribution of Cdc20 to D box-dependent substrate recognition by APC/C. In the sequential model, the D box first binds to Cdc20 and then to APC/C. In the composite binding pocket model, the D box-binding site is formed at the interface between APC/C and Cdc20. In the allostery model, Cdc20 binding triggers a conformational change on APC/C, revealing a D box-binding pocket. In the multivalency model, both Cdc20 and APC/C contain binding sites for the D box and other APC/C degrons. Simultaneous engagement of multiple degrons enhances the affinity between the substrate and APC/C Cdc20 .
arms of APC/C . These results raise an intriguing possibility that the simultaneous engagement of both APC/C-binding motifs of Cdh1 might bring the Cdc27-and APC2-containing arms of APC/C closer to each other, thus providing a possible explanation for the observed conformational change of APC/C induced by Cdh1 binding. Several lines of evidence are consistent with the multivalency model. Many APC/C substrates contain multiple degrons. Elimination of a single degron within a substrate often only reduces, but does not abolish, its APC/Cdependent ubiquitination (Fang et al., 1998b; Zur and Brandeis, 2001 ). Furthermore, APC/C contains multiple copies of certain subunits (Dube et al., 2005; . It is conceivable that each APC/C particle contains multiple copies of the putative receptor(s) for the APC/C degrons, readily explaining the finding that tandem copies of the D box bind to the APC/C core with high affinity. Finally, if both APC/C and Cdc20 contain weak but independent substrate-binding site(s), the multivalency model provides a straightforward explanation of the fact that APC/C Cdc20 complex binds substrate more tightly than either APC/C or Cdc20 alone. Taken together, the available data suggest that the APC/C Cdc20 and APC/ C Cdh1 complexes recognize substrates through a combination of allosteric and multivalency mechanisms. Cdc20 activates the ubiquitin ligase activity of APC/C by directly contributing to substrate recruitment and possibly by altering the conformation of the APC/C core particle.
Regulation of Cdc20
The timing of APC/C Cdc20 -mediated degradation of mitotic regulators is crucial for the proper progression through mitosis and is determined mostly by the activity profile of APC/C Cdc20 , though other factors, including the nature of the APC/C-binding cis elements of these substrates and their subcellular localization, also contribute to this process. The APC/C Cdc20 activity is restrained at multiple levels by several cellular mechanisms (Table 1) , which are discussed in detail below. A recurring theme is that many APC/C regulators restricting APC/C activity directly or indirectly are themselves APC/C substrates. An increase in APC/C activity is expected to cause a decrease in the levels of APC/C inhibitors, leading to further activation of APC/C. This mutually antagonistic relationship between APC/C and its regulators ensures the abrupt and irreversible transitions during mitosis. Transcription, Degradation, and Folding of Cdc20 Consistent with its role in mitosis, the protein level of Cdc20 starts to accumulate in S phase, peaks in mitosis, and drops sharply as cells exit from mitosis (Fang et al., 1998b) . This pattern of expression is largely due to the combined effects of the upregulation of CDC20 transcription in mitosis and APC/C Cdh1 -mediated degradation of Cdc20 in G1 (Fang et al., 1998b; Prinz et al., 1998) . Regulation of CDC20 transcription is best understood in the budding yeast. When studying the functions of Cks proteins (small CDK-associated proteins), Morris et al. unexpectedly discovered CDC20 as a multicopy suppressor of a cks1 temperature-sensitive mutant (Morris et al., 2003) . This finding prompted them to investigate whether Cks1 regulates the expression of CDC20. They showed that Cks1 binds directly to the CDC20 promoter. Two known interactors of Cks1, Cdc28 (yeast Cdk1) and the proteasome, undergo Cks1-dependent periodic association and dissociation with the CDC20 promoter during the cell cycle, which in turn are required for proper cell cycle regulated transcription of CDC20 (Morris et al., 2003) . It is unclear whether transcription of Cdc20 is similarly regulated by CDKs in vertebrate cells. APC/C Cdh1 is turned on in late anaphase and remains active during G1. Cdc20 is one of the many substrates of APC/C Cdh1 (Figure 2) . Degradation of yeast Cdc20 by APC/C Cdh1 requires a D box at its N terminus that is not conserved in vertebrate Cdc20 proteins (Prinz et al., 1998) . The search for the cis element in Xenopus Cdc20 that is required for APC/C-mediated ubiquitination led to the identification of the KEN box as an APC/C Cdh1 degron (Pfleger and Kirschner, 2000) . Recently, an additional motif called the CRY box that resembles the C box has been shown to contribute to APC/C Cdh1 -dependent Cdc20 degradation in mammalian oocytes and embryos ) ( Figure 1A) . A thorough understanding of how Cdc20 interacts with APC/C substrates and how the various cis elements within Cdc20 contribute to its function and regulation will only be possible with highresolution structures of Cdc20. Structural efforts on Cdc20 have so far failed, largely due to the difficulty in obtaining large quantities of pure, functional recombinant Cdc20. This difficulty stems in part from the fact that the folding of Cdc20 requires a multisubunit chaperonin called CCT (Camasses et al., 2003) . In yeast, CCT is required for all aspects of Cdc20 function and regulation (Camasses et al., 2003) . Cdc20 also associates with CCT in human cells (Z. Tang and H.Y., unpublished data), suggesting that the requirement for CCT in Cdc20 folding is conserved.
Regulation of APC/C Cdc20 by the Spindle Checkpoint During mitosis, sister chromatids are captured by spindle microtubules in a largely stochastic fashion. To ensure that chromosome segregation only occurs after all pairs of sister chromatids achieve proper attachment to the bipolar spindle, cells employ a surveillance mechanism called the spindle checkpoint to detect the existence of misaligned sister chromatids and to prevent premature sister-chromatid separation (reviewed in Bharadwaj and Yu [2004] ). Given the essential role of APC/C Cdc20 in triggering chromosome segregation, it is not surprising that APC/C Cdc20 is a key molecular target of the spindle checkpoint (Bharadwaj and Yu, 2004) . Genetic studies in budding yeast identified mitotic arrest deficiency (Mad)1-3 and budding uninhibited by benomyl (Bub)1-3 as core components of the spindle checkpoint (reviewed in Bharadwaj and Yu [2004] ). The vertebrate orthologs of the Mad and Bub proteins were then identified (Bharadwaj and Yu, 2004) . Subsequent biochemical analysis revealed that these proteins use multiple strategies to inhibit APC/C Cdc20 upon checkpoint activation. Stoichiometric binding of either Mad2 or BubR1 (the vertebrate ortholog of yeast Mad3) to Cdc20 inhibits APC/C Cdc20 in vitro (Fang et al., 1998a; Tang et al., 2001a) . Mad2, Mad3/BubR1, Bub3, and Cdc20 can form a single mitotic checkpoint complex (MCC) in vivo (Sudakin et al., 2001 ). In addition, Bub1 phosphorylates Cdc20 and inhibits APC/C Cdc20 catalytically (Tang et al., 2004) . Finally, in yeast, Mad2 and Mad3 binding to Cdc20 triggers the autoubiquitination of Cdc20 and reduces the protein level of Cdc20 (Pan and Chen, 2004) , although it remains to be determined whether this mechanism is conserved in other organisms. How does the spindle checkpoint detect the existence of sister chromatids that are not captured or are improperly captured by spindle microtubules and signal to the Mad and Bub proteins to inhibit APC/C Cdc20 ? Many if not all spindle checkpoint proteins are recruited to kinetochores that are not attached by spindle microtubules, the very cellular defects that the spindle checkpoint needs to detect and respond to. Fluorescence recovery after photobleaching (FRAP) experiments further revealed that the kinetochore-bound pools of BubR1, Mad2, and Cdc20 exchange rapidly with their cytosolic pools (Howell et al., 2004; Shah et al., 2004) . Furthermore, structural and biochemical analysis of Mad1 and Mad2 suggests that the kinetochore-bound Mad1 promotes a conformational change of Mad2, which is required for its efficient binding to Cdc20 (reviewed in Yu [2006] ). Finally, in Xenopus egg extracts, phosphorylation of Cdc20 by MAPK and Cdk1 is required for efficient Mad2 binding and for the spindle checkpoint (Chung and Chen, 2003; D'Angiolella et al., 2003) . These findings support an attractive model in which the unattached kinetochores facilitate the formation of APC/C-inhibitory checkpoint complexes containing BubR1, Bub3, Mad2, and Cdc20 by increasing the concentrations of these proteins locally, by triggering a conformational change of Mad2, and by posttranslational modifications on Cdc20. In addition, Bub1 bound to chromosomes exhibits higher autophosphorylation activity as compared to cytosolic Bub1 (Chen, 2004) , suggesting that unattached kinetochores might also stimulate the kinase activity of Bub1 toward Cdc20, thereby facilitating inhibition of APC/C Cdc20 . It remains to be determined whether phosphorylation of Cdc20 by Bub1 also enhances its binding to Mad2 or BubR1, similar to phosphorylation of Cdc20 by MAPK and Cdk1 (Chung and Chen, 2003; D'Angiolella et al., 2003) . In an alternative model, Yen and coworkers have proposed that MCC forms constitutively during the cell cycle, but it is only capable of associating with the APC/C core that is modified during mitosis by unattached kinetochores and spindle checkpoint signaling (Sudakin et al., 2001) . This model is inconsistent with the fact that the concentrations of MCC are much higher in mitosis than during interphase in several organisms (Chen, 2002; Millband and Hardwick, 2002) . Furthermore, no such spindle checkpoint-dependent modifications of APC/C that allow MCC binding in mitosis have been discovered so far.
Regardless of the competing models, it is generally agreed upon that checkpoint signal ultimately has to originate from the kinetochores of misaligned chromatids and is then distributed and amplified throughout the cell to exert inhibition of APC/C. Given the central role of kinetochores in spindle checkpoint signaling, it is critical to understand the kinetochore-targeting mechanisms of the spindle checkpoint proteins. A signaling network that recruits spindle checkpoint proteins to unattached kinetochores has been established by examining their interdependency at kinetochores in mammalian cells and in Xenopus egg extracts. In particular, several recent studies have highlighted the importance of Polo-like kinase 1 (Plk1) in this network (Figure 4) . The chromosome passenger complex (CPC) containing Aurora B, INCENP, survivin, and Dasra/Borealin recruits the Bub1-Bub3 complex and Mps1 to the kinetochores (Johnson et al., 2004; Vigneron et al., 2004) . The CPC and Bub1 collaborate to recruit Plk1 to kinetochores through Bub1-Plk1 and INCENP-Plk1 interactions (Goto et al., 2006; Qi et al., 2006) . Plk1 then facilitates the kinetochore recruitment of Cdc20 and the BubR1-Bub3 and Mad1-Mad2 complexes (Ahonen et al., 2005; Wong and Fang, 2005) . Plk1 phosphorylates and targets Plk1-interacting checkpoint helicase (PICH)-a member of the SNF2 family of DNA-binding ATPases-to kinetochores during prometaphase and to stretched centromeric chromatin that contains concatenated DNA in anaphase (Baumann et al., 2007) . PICH is specifically required for the kinetochore localization of Mad2, but not that of Mad1, suggesting that PICH maintains the Mad1-Mad2 interaction at the kinetochores in response to the lack of tension across the kinetochores (Baumann et al., 2007) . Interestingly, depletion of Nek2A also causes delocalization of Mad2 from kinetochores without affecting the kinetochore localization of Mad1 (Lou et al., 2004) . Very recently, Draviam et al. identified the protein kinase TAO1 as a novel spindle checkpoint protein in a functional RNAi screen . They further showed that TAO1 was required for the kinetochore localization of Mad2, but not other spindle checkpoint proteins examined, including Mad1. Therefore, upon checkpoint activation, an elaborate signaling network targets the Mad and Bub proteins to unattached/untensed kinetochores, which then promotes the formation of APC/C-inhibitory complexes.
It has been suggested that Mad2 binding to Cdc20 prevents the release of substrates (presumably ubiquitinated substrates, i.e., products of the ubiquitination reaction), thereby inhibiting APC/C Cdc20 (Pfleger et al., 2001) . It is unclear how binding of BubR1 to Cdc20 or Bub1-mediated phosphorylation of Cdc20 inhibits APC/C Cdc20 . Both Mad2 and BubR1 can be coimmunoprecipitated with core subunits of APC/C, such as Cdc27, in nocodazole-arrested mitotic human cells (Fang et al., 1998a; Sudakin et al., 2001) , suggesting that binding of Mad2 or BubR1 to APC/C does not dissociate Cdc20 from APC/ C. Likewise, phosphorylated Cdc20 remains bound to APC/C in mitosis. Thus, Mad2, BubR1, and Bub1 inhibit APC/C Cdc20 through interfering with the function of Cdc20 at a step that is subsequent to Cdc20 binding to APC/C, possibly substrate recruitment and/or product release. Though counterintuitive, this mode of APC/C Cdc20 inhibition by the spindle checkpoint is in fact advantageous for the following reasons. While the spindle checkpoint inhibits the ubiquitin ligase activity of APC/C toward securin and cyclin B, it does not block degradation of certain APC/ C Cdc20 substrates, such as cyclin A and Nek2A (Geley et al., 2001; Hayes et al., 2006) . Nek2A uses a C-terminal motif resembling the IR box of Cdh1 and Cdc20 to interact with the APC/C core, thereby bypassing a requirement for Cdc20 in substrate binding and rendering its degradation refractory to checkpoint inhibition (Hayes et al., 2006) . Interestingly, Cdc20 is still required for the degradation of Nek2A (Hayes et al., 2006) , consistent with the notion that Cdc20 allosterically activates APC/C. Therefore, by not disrupting the interaction between APC/C and Cdc20, the spindle checkpoint is able to achieve substrate-specific inhibition of APC/C Cdc20 . A second benefit of allowing the association of Mad2-and BubR1-bound Cdc20 with APC/C is to provide an opportunity for Cdc20 autoubiquitination by APC/C. As discussed above, one function of Cdc20 autoubiquitination, at least in yeast, is to reduce the protein levels of Cdc20, thus facilitating inhibition of APC/C Cdc20 by the spindle checkpoint (Pan and Chen, 2004) . As revealed by two recent studies, another function of Cdc20 autoubiquitination is to dissociate Mad2 from Cdc20 and to inactivate the spindle checkpoint (Reddy et al., 2007; Stegmeier et al., 2007) (Figure 4) . Reddy et al. discovered that overexpression of UbcH10, the UBC that supports APC/C-catalyzed ubiquitination reactions, in human cells prevented them from arresting in mitosis in the presence of nocodazole (Reddy et al., 2007) . Addition of exogenous UbcH10 protein to extracts of nocodazole-arrested mitotic cells increases Cdc20 autoubiquitination, disrupts the Mad2-Cdc20 interaction, and activates APC/C. Consistent with earlier studies that established a role of p31 comet (a conformation-specific Mad2-binding protein) in checkpoint inactivation (Xia et al., 2004) , addition of p31 comet and UbcH10 together has a synergistic effect on Cdc20 autoubiquitination, disassembly of the Mad2-Cdc20 complex, and checkpoint inactivation (Reddy et al., 2007) . Moreover, cells depleted of UbcH10 and p31 comet by RNAi failed to recover from a nocodazoleinduced mitotic arrest due to their inability to disassemble Mad2-Cdc20-containing checkpoint complexes. This study thus implicates Cdc20 autoubiquitination as an important mechanism for regulating the Mad2-Cdc20 interaction and for checkpoint inactivation.
In an accompanying paper, Stegmeier et al. systematically and individually depleted genes involved in the ubiquitin pathway from HeLa cells by short hairpin RNA (shRNA) transfections and assayed the RNAi cells for their ability to bypass Taxol-induced mitotic arrest . This led to the identification of USP44, a ubiquitin isopeptidase, as a novel spindle checkpoint protein.
In addition to a role in Taxol-induced mitotic arrest, USP44 was also required for the proper timing of mitotic events during the normal cell cycle-a function shared by Mad2 and BubR1 (Meraldi et al., 2004) . While the kinetochore localization of Mad2 was not altered in USP44 RNAi cells, Mad2 failed to interact with Cdc20 efficiently in these cells . USP44 antagonized the ability of UbcH10 and p31 comet to induce the disruption of the Mad2-Cdc20 interaction and APC/C activation in vitro. Importantly, the isopeptidase activity of USP44 is required for spindle checkpoint signaling in cells and Upon checkpoint activation, an elaborate signaling network targets the spindle checkpoint proteins to unattached kinetochores. The chromosome passenger complex (CPC) containing Aurora B and INCENP recruits Bub1-Bub3. Phosphorylation of INCENP and Bub1 by Cdk1 creates docking sites for the polo-box domain of Plk1, targeting Plk1 to kinetochores. Plk1 then facilitates the kinetochore localization of PICH, Mad1-Mad2, BubR1-Bub3, and Cdc20. The close proximity of Cdc20 and the checkpoint proteins at kinetochores and a Mad1-triggered conformational change of Mad2 facilitate the formation of the mitotic checkpoint complex (MCC) containing BubR1, Bub3, Mad2, and Cdc20, which associates with and inhibits APC/C. Phosphorylation of Cdc20 by Bub1 also inhibits APC/C Cdc20 . The concentration of Mad2-Cdc20-containing checkpoint complexes is controlled by two opposing dynamic processes: kinetochore-facilitated formation and p31 comet -and UbcH10-dependent disassembly through Cdc20 autoubiquitination. Protectin deubiquitinates Cdc20 and maintains the Mad2-Cdc20 interaction, contributing to checkpoint activation. When the kinetochores are captured by spindle microtubules and are under tension, the concentrations of checkpoint proteins at kinetochores and possibly their activities in certain cases decrease. p31 comet binds to Mad1-bound Mad2, preventing the generation of the active conformer of Mad2. These mechanisms reduce the rate of formation of Mad2-Cdc20. Meanwhile, p31 comet binds to Cdc20-bound Mad2 and, along with UbcH10, stimulates the autoubiquitination of Cdc20 and the disassembly of Mad2-Cdc20. This leads to checkpoint inactivation and activation of APC/C Cdc20 , which indirectly activates APC/C Cdh1 . APC/C Cdh1 then targets several spindle checkpoint proteins for degradation, including Plk1, Aurora B, Mps1, and Bub1, and prevents the reestablishment of the spindle checkpoint following mitotic exit. appears to be activated by phosphorylation during mitosis. Activated recombinant USP44 directly removed ubiquitin from ubiquitinated Cdc20. Cdc20 autoubiquitination was enhanced in USP44 RNAi cells. Thus, this elegant study by Stegmeier et al. clearly establishes USP44 as a novel spindle checkpoint protein . They have renamed USP44 protectin to reflect its role in reversing Cdc20 autoubiquitination and consequently protecting the Mad2-Cdc20-containing checkpoint complexes from disassembly . Collectively, these two studies demonstrate that cellular concentrations of Mad2-Cdc20 and the activation status of the spindle checkpoint depend on the delicate balance between two opposing dynamic processes, providing a fast on-or-off switch for the spindle checkpoint (Reddy et al., 2007; Stegmeier et al., 2007) . It is unclear whether UbcH10-and p31 comet -dependent Cdc20 autoubiquitination and the activity of protectin are directly regulated by the spindle checkpoint.
Regulation of APC/C Cdc20 by Emi1 and Erp1/Emi2
Both early mitotic inhibitor 1 (Emi1) and its homolog Erp1/ Emi2 contain a C-terminal Zn
2+
-binding region (ZBR) and an F box that mediates their binding to Skp1 (reviewed in Schmidt et al. [2006] ). Prompted by the sequence similarity between Emi1 and the Drosophila regulator of cyclin A (Rca1) protein, Reimann et al. examined the function and regulation of Emi1 in Xenopus egg extracts (Reimann et al., 2001a) . They showed that Emi1 interacts with Cdc20 and inhibits APC/C Cdc20 . Inhibition of APC/C Cdc20 by Emi1 requires the ZBR domain of Emi1, but does not require its F box. Depletion of Emi1 from Xenopus egg extract prevents the accumulation of cyclin B and consequently entry into mitosis. Conversely, overexpression of Emi1 causes mitotic arrest in cells, due to a failure to degrade cyclins A and B. The Emi1 protein accumulates in S phase and is degraded during mitosis. This work established Emi1 as an early mitotic inhibitor of APC/C (Figure 2) . Subsequent studies then revealed that Cdk1 and Plk1 collaborate to phosphorylate Emi1 and create a phospho-Ser/Thr-containing degradation motif that is recognized by bTrCP, the aforementioned adaptor for the SCF ubiquitin ligases, resulting in the ubiquitination and degradation of Emi1 (Margottin-Goguet et al., 2003; Moshe et al., 2004) . The timing of Emi1 degradation in early mitosis is also controlled by its association with Pin1, an isomerase that specifically catalyzes the cis/trans isomerization of phosphorylated Ser/Thr-Pro motifs (Bernis et al., 2007) . Pin1-mediated isomerization of such motifs in Emi1 that are phosphorylated by Cdk1 appears to prevent binding of bTrCP and stabilize Emi1 in G2 (Bernis et al., 2007) . Thus, the expression profile of Emi1 suggests that it prevents the premature activation of APC/C Cdc20 and the untimely demise of Cdk1, prior to the establishment of the spindle checkpoint in early mitosis. In addition to its mitotic functions, Emi1 also inhibits APC/C Cdh1 and has additional roles at the G1-S transition (Hsu et al., 2002) and in preventing DNA rereplication (Machida and Dutta, 2007) . In late G1 phase, the E2F family of transcription factors activate the transcription of Emi1 (Hsu et al., 2002) (Figure 2 ). Evi5, a GTPase-activating protein (GAP) for Rab11 (Westlake et al., 2007) , binds to Emi1 and prevents its phosphorylation by Plk1 and its interaction with bTrCP, thereby stabilizing the Emi1 protein (Eldridge et al., 2006) . These two mechanisms cause the accumulation of the Emi1 protein in late G1. Emi1 then inhibits the activity of APC/C Cdh1 and stabilizes cyclin A, promoting the entry into S phase (Hsu et al., 2002) . Emi1-dependent inhibition of APC/C Cdh1 is also required for maintaining the levels of cyclin A and geminin in S and G2, thus preventing DNA rereplication (Machida and Dutta, 2007) . Unlike Emi1 that has multiple functions during the somatic cell cycle, Erp1/Emi2 functions primarily during meiosis and the embryonic cell cycle Tung et al., 2005) . Prior to fertilization, mature eggs of many vertebrate species are arrested at metaphase of meiosis II by the cytostatic factor (CSF) (Schmidt et al., 2006) . A number of recent studies have established Erp1/Emi2 as an essential component of CSF in Xenopus Tung et al., 2005) . Erp1 inhibits APC/ C Cdc20 and selectively stabilizes cyclin B, thus maintaining high levels of Cdk1 activity and metaphase arrest in the mature egg. Upon fertilization, the elevation of intracellular Ca 2+ concentrations activates Ca 2+ /calmodulin-dependent kinase II (CaMKII), which phosphorylates Erp1 and creates a docking site for the polo-box domain of Plx1 (Xenopus Plk1) . Similar to Emi1, Erp1 phosphorylated by Plx1 is recognized and ubiquitinated by SCF bTrCP . Degradation of Erp1 relieves the inhibition of APC/C Cdc20 , leading to inactivation of Cdk1 and the exit from CSF-mediated metaphase arrest .
How do Emi proteins inhibit APC/C? Earlier studies have suggested that Emi1 directly binds to Cdc20 and Cdh1 and prevents their association with substrates, thereby inhibiting APC/C (Reimann et al., 2001a (Reimann et al., , 2001b . However, this view has been modified by a recent study (Miller et al., 2006) , which demonstrated that Emi1 tightly binds to the APC/C core and this binding is mainly mediated by an interaction between a D box on Emi1 and the putative D box receptor of the APC/C core. Mutation of the ZBR domain converts Emi1 from an APC/C inhibitor to a D box-dependent APC/C substrate (Miller et al., 2006) . These findings establish Emi1 as a pseudosubstrate inhibitor. In addition to binding to Cdc20 and Cdh1, Emi1 competes with other APC/C substrates for binding to the D box-binding site(s) on the APC/C core. The C-terminal ZBR domain protects Emi1 from being ubiquitinated by APC/C, though the mechanism by which the ZBR does this is unclear. A recent study demonstrates that, similar to Emi1, Erp1 also uses a pseudosubstrate mechanism to inhibit APC/C Cdc20 (Nishiyama et al., 2007) . Though first identified as an F box-containing protein, the role of the F box of Emi1 has remained obscure. While the F box of Emi1 is functional and can bind to Skp1, it is not required for APC/C inhibition by Emi1 or the degradation of Emi1 in early mitosis (Reimann et al., 2001a) . Recently, the F box of Rca1 (the Drosophila homolog of Emi1) has been shown to be required for the G1-S transition (Zielke et al., 2006) . Moreover, Rca1 interacts physically with SkpA and Cul1, suggesting that Rca1 serves as an adaptor of an SCF-type ubiquitin ligase and targets an unknown negative regulator of the G1-S transition for degradation (Zielke et al., 2006) . Whether the F box of Emi1 homologs in other species performs a similar function remains to be determined. Additional Mechanisms that Regulate APC/C
Cdc20
In mammalian cells, the DNA damage checkpoint blocks the cell cycle at multiple junctures in response to DNA damage, including the G2-M transition. Due to the lack of a defined G2 phase in its cell cycle, the DNA damage checkpoint in the budding yeast blocks the metaphaseanaphase transition (instead of the G2-M transition) in two ways. Upon DNA damage, the proximal checkpoint kinase Mec1 activates the signal transducing kinase Chk1, which then phosphorylates Pds1 (the budding yeast securin). Phosphorylation of Pds1 by Chk1 stabilizes Pds1 by preventing its APC/C-dependent degradation (Wang et al., 2001) . Consistently, Pds1 phosphorylated by Chk1 is a poorer substrate for APC/C in vitro (Agarwal et al., 2003) . Therefore, Chk1-dependent phosphorylation of Pds1 is one mechanism that the DNA damage checkpoint uses to block the metaphase-anaphase transition. A second mechanism is phosphorylation of Cdc20 by protein kinase A (PKA) (Searle et al., 2004) . Under DNA-damaging conditions, Cdc20 undergoes PKA-dependent phosphorylation at its N-terminal domain (Searle et al., 2004) . Expression of a Cdc20 mutant that is no longer phosphorylatable by PKA or inhibition of the PKA pathway in Chk1 null cells causes degradation of Pds1 and Clb2 with faster kinetics in the presence of telomere-associated DNA damage (Searle et al., 2004) . Phosphorylation of Cdc20 by PKA reduces the binding between Cdc20 and its substrates, such as Clb2, and diminishes APC/C-dependent degradation of Pds1 and Clb2 (Searle et al., 2004) , although it remains to be tested whether phosphorylation of Cdc20 by PKA inhibits APC/C Cdc20 in vitro. It is also unclear whether Cdc20 is regulated by the DNA damage checkpoint and the PKA pathway in organisms other than the budding yeast.
RASSF1A is a tumor suppressor that is frequently inactivated in lung cancer patients through promoter methylation. Song et al. recently showed that RASSF1A directly interacted with Cdc20 and inhibited APC/C Cdc20 in vitro whereas it did not inhibit APC/C Cdh1 (Song et al., 2004) . Overexpression of RASSF1A in human cells caused accumulation of both cyclin A and cyclin B and a prometaphase block while depletion of RASSF1A resulted in premature degradation of mitotic cyclins and a slightly accelerated mitosis. It was proposed that RASSF1A functions independently of the spindle checkpoint and Emi1 to restrict the activity of APC/C Cdc20 during early mitosis (Song et al., 2004) . On the other hand, earlier studies showed that overexpression of RASSF1A prevented the accumulation of cyclin D and caused a G1 arrest (Shivakumar et al., 2002) , a phenotype that was not observed by Song et al. Furthermore , it is unclear how the reported mitotic functions of RASSF1A contribute to tumor suppression. These issues need to be resolved by additional experiments. Finally, human Mad2B, a protein with sequence similarity to both Mad2 and the Rev7 subunit of the error-prone DNA polymerase z complex involved in DNA translesion synthesis, inhibits APC/C Cdc20 and APC/C Cdh1 in vitro (Chen and Fang, 2001; Pfleger et al., 2001 ). Mad2B interacts with other components of human Pol z (Murakumo et al., 2000) . Depletion of Mad2B from human cells by RNAi renders them hypersensitive to DNA-damaging agents, especially ionizing radiation (IR) (Cheung et al., 2006) . Mad2B-deficient cells have decreased capacity to repair DNA double-strand breaks by homologous recombination using sister chromatids as the template (Cheung et al., 2006) . Thus, human Mad2B is clearly a component of Pol z and plays a role in DNA damage response. In contrast, Mad2B-deficient cells lack discernible mitotic phenotypes and arrest normally in mitosis in the presence of nocodazole, suggesting that, unlike Mad2, Mad2B is not required for the spindle checkpoint (Cheung et al., 2006) . This result calls into question the in vivo relevance of Mad2B as an APC/C Cdc20 inhibitor.
Concluding Remarks
First identified as a protein essential for cell-cycle progression in the budding yeast, Cdc20 has since emerged as the major mitotic activator of APC/C, a large cell cycle degradation machine. The C-terminal WD40 repeat domain of Cdc20 is predicted to fold into a seven-bladed b propeller that has an ideal architecture for simultaneously engaging in multiple protein-protein interactions. As such, Cdc20 appears to bridge the interactions between APC/C and its substrates. There is also evidence to suggest that Cdc20 activates APC/C in an allosteric manner. Due to its essential roles in mitotic progression, APC/C Cdc20 is subjected to multiple layers of regulation, most of which converge on Cdc20. The expression profile of Cdc20 is regulated at the transcriptional and posttranslational levels. Binding of numerous cofactors, including Mad2, BubR1, and Emi1, and phosphorylation of Cdc20 by various kinases, including Bub1, MAPK, Cdk1, and PKA, collectively confer temporal and spatial control of the activity of APC/C Cdc20 during the normal somatic cell cycle and under spindle-or DNA-damaging conditions. APC/C Cdc20 is also inhibited by Erp1/Emi2, which is the principal molecular component of the CSF during the embryonic cell cycle. In the future, high-resolution structural studies on Cdc20 and its associated factors are needed to fully understand how Cdc20 activates APC/C and how binding of inhibitory factors to Cdc20 inhibits APC/C Cdc20 , especially given the possible involvement of allostery in these processes. In addition, because Cdc20 is the target of multiple cell cycle regulatory pathways, a thorough understanding of Cdc20 regulation will require a systems approach that analyzes the contributions of each pathway quantitatively and with finer spatial and temporal resolution in living cells.
